Exodus Point Capital Management, LP Rocket Pharmaceuticals, Inc. Transaction History

Exodus Point Capital Management, LP

$11.4 Billion
Q2 2025

A detailed history of Exodus Point Capital Management, LP transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 165,037 shares of RCKT stock, worth $559,475. This represents 0.0% of its overall portfolio holdings.

Number of Shares

165,037

Previous 200,684 17.76%

Holding current value

$559,475

Previous $1.34 Million 69.83%

% of portfolio

0.0%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	SELL	$2.33 - $8.01 $83,057 - $285,532	-35,647 Reduced 17.76%	165,037 $404,000
Q1 2025 May 14, 2025	BUY	$6.67 - $12.72 $72,069 - $137,439	10,805 Added 5.69%	200,684 $1.34 Million
Q4 2024 Feb 12, 2025	BUY	$11.35 - $18.82 $1.41 Million - $2.34 Million	124,261 Added 189.37%	189,879 $2.39 Million
Q3 2024 Nov 12, 2024	BUY	$17.6 - $25.88 $1.15 Million - $1.7 Million	65,618 New	65,618 $1.21 Million
Q2 2023 Aug 10, 2023	SELL	$16.59 - $23.6 $4.5 Million - $6.4 Million	-271,264 Reduced 88.63%	34,798 $691,000
Q1 2023 May 11, 2023	BUY	$15.79 - $22.6 $4.83 Million - $6.92 Million	306,062 New	306,062 $5.24 Million
Q3 2022 Nov 10, 2022	BUY	$12.37 - $18.41 $244,022 - $363,174	19,727 Added 111.61%	37,402 $597,000
Q2 2022 Aug 19, 2022	SELL	$7.96 - $16.64 $22,439 - $46,908	-2,819 Reduced 13.76%	17,675 $243,000
Q1 2022 May 13, 2022	BUY	$13.16 - $23.68 $269,701 - $485,297	20,494 New	20,494 $325,000
Q1 2021 May 17, 2021	SELL	$43.34 - $65.91 $1.56 Million - $2.38 Million	-36,085 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$23.3 - $59.57 $151,822 - $388,158	6,516 Added 22.04%	36,085 $1.98 Million
Q3 2020 Nov 16, 2020	BUY	$20.5 - $28.59 $606,164 - $845,377	29,569 New	29,569 $676,000
Q1 2020 May 15, 2020	SELL	$9.71 - $25.11 $301,534 - $779,765	-31,054 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$11.07 - $24.23 $204,285 - $447,140	18,454 Added 146.46%	31,054 $707,000
Q3 2019 Nov 14, 2019	BUY	$10.85 - $14.78 $136,710 - $186,228	12,600 New	12,600 $147,000

Others Institutions Holding RCKT

# of Institutions

222

Shares Held

98.5M

Call Options Held

611K

Put Options Held

474K

View Full List

About ROCKET PHARMACEUTICALS, INC.

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $257M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

More about RCKT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.

Account

Exodus Point Capital Management, LP Rocket Pharmaceuticals, Inc. Transaction History